The GI tract is inhabited by trillions of commensal bacteria that play crucial roles in human physiology^[@R1]^. This fundamental relationship between the host and microbiota relies on chemical signaling and nutrient availability^[@R2]^, and invading pathogens compete for these resources through the precise coordination of virulence traits. EHEC colonizes the colon, leading to hemorrhagic colitis^[@R7]^. EHEC colonization depends on the locus of enterocyte effacement (LEE) pathogenicity island (PAI)^[@R7]^. This PAI encodes a regulator for its own expression, *ler*, and a molecular syringe, a type-3 secretion system (TTSS), which injects effectors into the host cell, leading to the formation of attaching and effacing (AE) lesions on enterocytes. AE lesions are characterized by remodeling of the host-cell cytoskeleton, leading to the formation of a pedestal-like structure beneath the bacteria^[@R7]^. LEE expression is regulated by an inter-kingdom chemical signaling system involving the host hormones epinephrine and/or norepinephrine and the microbial-flora-produced signal autoinducer-3 (AI-3)^[@R8]^. These signals are sensed by two HKs, QseC^[@R3]^ and QseE^[@R4]^, which initiate a signaling cascade that promotes virulence.

HKs, together with RRs comprise a two-component system (TCS), which play a major role in bacterial signal transduction. Upon sensing a signal, the HK autophosphorylates and then transfers its phosphate to the RR. Subsequently, most RRs bind DNA, promoting changes in gene expression^[@R9]^. The cognate RR for QseC is QseB, and for QseE is QseF ([Fig. 1a](#F1){ref-type="fig"}). QseBC and QseEF repress expression of the *z0462/z0463* genes ([Fig. 1b](#F1){ref-type="fig"})^[@R10]--[@R11]^. QseB repression of *z0462/z0463* expression is direct, while QseF-mediated repression is indirect ([Fig. 1c, d](#F1){ref-type="fig"}), in agreement with QseF being a σ^54^-dependent transcriptional activator^[@R12]^. QseF activates the expression of a repressor of *z0462/z0463*.

The *z0462/z0463* genes are within a PAI \[O-island 20 (OI-20)\]^[@R13]^, which is found in EHEC O157:H7 strains and enteropathogenic *E.coli* strains exclusively from the 055:H7 serotype (which gave rise to the O157:H7 serotype), but absent in all other *E. coli* strains whose genomes are currently publically available. This PAI is organized in three transcriptional units ([Supplementary Fig. 1](#SD1){ref-type="supplementary-material"}). The genes *z0462*/*z0463* encode for a putative TCS: *z0462* encodes a HK with 8 transmembrane domains that shares similarity to a glucose-6-phosphate sensor, UhpB (\~30%); *z0463* encodes a RR with a receiver and a DNA-binding domain ([Supplementary Fig. 2](#SD1){ref-type="supplementary-material"}). Z0462 in liposomes is a functional HK ([Fig. 1e](#F1){ref-type="fig"}), and it transfers its phosphate to Z0463 ([Fig. 1f](#F1){ref-type="fig"}). Hence Z0462 and Z0463 constitute a cognate TCS.

Transcriptomic studies ([Supplementary Tables 4,5](#SD1){ref-type="supplementary-material"}) suggested that Z0462/Z0463 mainly act as repressors of transcription. Z0462/Z0463 represses LEE gene expression ([Supplementary Fig. 3](#SD1){ref-type="supplementary-material"}). Transcription of all LEE operons is increased inΔ*z0462* and Δ*z0463*, and complementation restored the expression of *ler* to WT levels ([Fig. 2a--d](#F2){ref-type="fig"}). Transcription of the LEE genes is activated by Ler^[@R14]^. The RR Z0463 directly represses *ler* transcription*,* and subsequently the other *LEE* operons, and phosphorylation of Z0463 increases its affinity to *ler* ([Fig. 2e, f](#F2){ref-type="fig"}, [Supplementary Figs.6--8](#SD1){ref-type="supplementary-material"}). Congruent with the increased *LEE* transcription, both Δ*z0462* and Δ*z0463* secreted more EspB, a LEE-encoded protein ([Fig. 2g](#F2){ref-type="fig"}), and formed more pedestals than WT ([Fig. 2h, i](#F2){ref-type="fig"}). Therefore, Z0462/Z0463 repress AE lesion formation. However, expression of other genes encoding non-LEE-encoded-TTSS effectors, not involved in AE lesion formation, are activated by Z0462/Z0463 ([Supplementary Fig. 4](#SD1){ref-type="supplementary-material"}).

Expression of *z0463* is increased by mucus produced by intestinal HT29 cells. EHEC infected undifferentiated HT29 cells were used as negative controls, since they do not produce mucus ([Fig. 3a](#F3){ref-type="fig"} and [Supplementary Fig. 9](#SD1){ref-type="supplementary-material"}). Z0462 is a predicted hexose-phosphate-sensor, hence, Z0462 may sense sugars in the mucus. Fucose is a major component of mucin glycoproteins, it is abundant in the intestine^[@R5]^, and fucose utilization is important for EHEC intestinal colonization^[@R15]--[@R16]^. In *E.coli*, L-fucose utilization requires the *fuc* genes, and their activator (FucR)^[@R17]^. Z0462/Z0463 repress the expression of the *fuc* genes ([Fig. 3b](#F3){ref-type="fig"}), andΔ*z0462* and Δ*z0463* grow faster with L-fucose as a sole carbon (C)-source compared to WT (generation times: WT 92.4min, Δ*z0462* 64min and Δ*z0463* 74min) ([Fig. 3c](#F3){ref-type="fig"}). Therefore, Z0462/Z0463 regulates fucose utilization, and this response is specific to fucose, with the mutants and WT growing at similar rates with other C-sources ([Supplementary Fig. 10](#SD1){ref-type="supplementary-material"}). Z0462 senses fucose, but not glucose nor D-ribose ([Fig. 3d, e](#F3){ref-type="fig"}). The concentration of fucose (100μM) used is physiologically relevant to the mammalian intestine^[@R18]^. Hence we renamed this protein FusK for fucose-sensing-HK, and its cognate RR, FusR for fucose-sensing-RR.

FusKR shares homology to the UhpAB TCS. UhpAB senses glucose-6-phosphate and activates expression of the *uhpT* gene that encodes a hexose-phosphate-major facilitator-superfamily (MFS) transporter^[@R19]--[@R21]^. FusKR represses transcription of the *z0461* gene downstream of *fusKR*, which encodes a predicted MFS ([Fig. 3f, g](#F3){ref-type="fig"} and [Supplementary Figs.3,11](#SD1){ref-type="supplementary-material"}). Δ*z0461* has decreased growth with fucose as a sole C-source (generation times: WT is 88.2min and Δ*z0461* 96.6 min) ([Fig. 3h](#F3){ref-type="fig"}), but grows similar to WT with glucose ([Supplementary Fig. 12](#SD1){ref-type="supplementary-material"}), suggesting that *z0461* is involved in optimal fucose import. Transcription of the *fuc* operons is linked to fucose uptake, fucose yields fuculose-1-phosphate that is the inducer of the FucR activator of the *fuc* operons^[@R17],[@R22]--[@R23]^. Transcription of the *fuc* genes is decreased in Δ*z0461* ([Fig. 3i](#F3){ref-type="fig"}). Fucose induces FusKR, which represses *z0461*, decreasing fucose import and the intracellular levels of the fuculose-1-phosphate inducer of FucR. In further support of this indirect regulation of the *fuc* genes, FusR does not bind to the *fucPIKUR* promoter region ([Supplementary Fig. 13](#SD1){ref-type="supplementary-material"}), in contrast to the direct regulation of the LEE ([Fig. 2](#F2){ref-type="fig"}).

TheΔ*fusK* is irresponsive to fucose, given that expression of *ler* is repressed by fucose in the WT but not in Δ*fusK* ([Fig. 4a](#F4){ref-type="fig"}). *B.theta* produces multiple fucosidases that cleave fucose from host glycans, resulting in high fucose availability in the lumen^[@R2]^. *B.theta* supplies mucin-derived fucose to EHEC, reducing *ler* expression, whereas in free fucose there is no change in *ler* expression whether *B.theta* is present ([Fig. 4b](#F4){ref-type="fig"}). Of note, expression of *ler* is decreased when EHEC is grown in mucin compared to fucose ([Fig. 4b](#F4){ref-type="fig"}), consistent with the increased expression of *fusR* in mucin ([Fig. 3a](#F3){ref-type="fig"}).

*In vitro* competitions between Δ*fusK* and WT, and Δ*fusK* and Δ*ler* (does not express the LEE) in the absence and presence of *B.theta*, with either fucose or mucin as a sole C-source were performed. The competition index (CI) between Δ*fusK* and WT was 1 ([Supplementary Fig. 14a](#SD1){ref-type="supplementary-material"}) both in the absence or presence of *B.theta* during growth in fucose, suggesting that in the presence of free fucose, *B.theta* does not impact the competition between Δ*fusK* and WT, and that the growth advantage of Δ*fusK* in fucose is counteracted by the WT, which has decreased LEE expression. When these experiments were performed with mucin as a sole C-source the CI between Δ*fusK* and WT was 0.1 in the absence, and 1 in the presence of *B.theta* ([Supplementary Fig. 14b](#SD1){ref-type="supplementary-material"}). In the absence of *B.theta* there is no free-fucose, hence Δ*fusK* will not have a growth advantage. Furthermore, Δ*fusK* over-expresses the LEE, which constitutes an energy burden. Meanwhile, expression of *fusKR* is activated in mucus ([Fig3a](#F3){ref-type="fig"}), further repressing the LEE in the WT. This scenario, however, reverts to a CI of 1 in the presence of *B.theta*, which releases fucose from mucin, conferring a growth advantage to Δ*fusK*, counteracting the WT ([Supplementary Fig. 14b](#SD1){ref-type="supplementary-material"}). Similar results were obtained in competitions between Δ*fusK* and Δ*ler*, consistent with the role of LEE gene expression being an energy burden in Δ*fusK* ([Supplementary Fig. 14c](#SD1){ref-type="supplementary-material"}).

The intricate role of FusK in EHEC's metabolism and virulence plays a role in intestinal colonization. Competition assays in infant rabbits demonstrated that the WT outcompeted Δ*fusK* 10-fold (CI of 0.12), which is statistically different (*p*=0.039) from a control competition assay, where the WT (*lacZ*+) was competed against a Δ*lacZ* (CI of 0.7) ([Fig. 4c](#F4){ref-type="fig"}). Hence, a functional FusK is necessary for robust EHEC intestinal colonization. To tease out whether the decreased ability of Δ*fusK* to colonize the mammalian intestine was due to uncontrolled expression of the LEE and/or fucose utilization, we performed competition experiments between WT and Δ*fusK*Δ*fucR*, which does not express the *fuc* genes. The double mutant was outcompeted by the WT with a similar CI to the Δ*fusK*/WT ([Fig. 4c](#F4){ref-type="fig"}), suggesting that fucose utilization does not play a major role in FusK-mediated intestinal colonization, and the burden of LEE over-expression by Δ*fusK* is a stronger determinant of its decreased fitness within the intestine.

FusKR repression of LEE expression in the mucus-layer prevents superfluous energy expenditure. Once in close contact to the epithelial surface, the QseCE adrenergic sensing-systems are triggered to activate virulence both directly through the QseCE cascade, and indirectly by repression of *fusKR* ([Supplementary Fig. 15](#SD1){ref-type="supplementary-material"}). EHEC competes with commensal *E.coli* (γ-*Proteobacteria*), but not *B.theta*, for the same C-sources (e.g. fucose) within the mammalian intestine^[@R15],[@R24]--[@R28]^. Commensal *E.coli*, however, are not found in close contact with the epithelia, being in the mucus-layer, where it is counterproductive for EHEC to invest resources to utilize fucose, when EHEC can efficiently use other C-sources such as: galactose, hexorunates, and mannose, which are not used by commensal *E.coli* within the intestine^[@R15]^. Additionally, in contrast to commensal *E.coli,* EHEC is found closely associated with the intestinal epithelium^[@R25]^. Therefore, EHEC can utilize nutrients exclusively available at the surface of the epithelial cells. Consequently, the decreased expression of the *fuc* operon through fucose-sensing by FusKR ([Fig. 3](#F3){ref-type="fig"}), may prevent EHEC from expending energy in fucose utilization in the mucus-layer, where it competes with commensal *E.coli* for this resource, and focus on utilizing other C-sources, not used by this competitor. Thus, the colonization defect of Δ*fusK* results from its inability to correctly time virulence and metabolic gene expression.

METHODS {#S2}
=======

Bacterial Strains, Plasmids and Growth Conditions {#S3}
-------------------------------------------------

Strains and plasmids are listed in [Supplemental Tables 1 and 2](#SD1){ref-type="supplementary-material"}. *E. coli* strains were grown aerobically at 37°C in DMEM (Gibco) or LB unless otherwise stated. For studies involving fucose utilization, bacterial cultures were grown in M9 minimal media containing 0.4% L-fucose, D-glucose, L-rhamnose, D-galactose or D-xylose (Sigma) as a sole carbon source. For the co-culture experiments between EHEC and *B. thetaiotaomicron*, these strains were grown anaerobically at 37°C in DMEM (lacking glucose and pyruvate) with or without mucin or free fucose, at a 1:1 ratio. Enumeration of EHEC was performed through serial dilution of these cultures in McConkey agar containing streptomycin (EHEC strain 86-24 is streptomycin resistant, while *B. thetaiotaomicron* is sensitive to this antibiotic). Enumeration of *B. thetaiotaomicron* was performed through serial plating in TYG medium supplemented with 10% horse blood in the presence of gentamycin (*B. thetaiotaomicron* is gentamycin resistant, while EHEC is sensitive to this antibiotic)

Recombinant DNA techniques {#S4}
--------------------------

Molecular biology techniques were performed as previously described^[@R29]^. Primers used in qRT-PCR and cloning are listed in [supplemental Table 2](#SD1){ref-type="supplementary-material"}.

Isogenic mutant construction {#S5}
----------------------------

Construction of isogenic *fusK, fusR, z0461, ler* and *fusKfucR* mutants was performed using a lambda-red mediated recombination method as previously described^[@R30]^. Primers used to construct these knockouts are depicted in [Supplemental Table 3](#SD1){ref-type="supplementary-material"}. Briefly: a mutagenic PCR product was generated using primers containing homologous regions to sequences flaking *z0462* (for *fusK* mutant), *z0463* (*fusR* mutant), *z0461, ler, and fucR* to amplify a chloramphenicol resistance gene from pKD3. 86-24 cells harboring pKD46 were electroporated using the mutagenic PCR product and selected for chloramphenicol (Cm) resistance. Nonpolar mutants were generated by resolving the Cm resistant clones with resolvase encoded by pCP20. For complementation of the mutants, *z0462* and *z0463* previously cloned in ZeroBlunt TOPO, digested with BamHI and SalI then cloned into pACYC184, generating the plasmid pARP12 and pARP13, respectively. pARP12 was electroporated into fusK- to generate ARP09 complemented strain; pARP13 was electroporated into fusR- to generate ARP10 complemented strain.

FusR purification {#S6}
-----------------

FusR was cloned into ZeroBlunt TOPO, digested using XhoI and HindIII restriction sites then cloned into pBADMycHisA, generating pARP11. pARP11 was subsequently transformed into TOP10 cells, generating the ARP04 strain. ARP04 strain was grown in LB to OD~600~ 0.6 at 37°C, at which point protein expression was induced by addition of a final concentration of 0.2% arabinose and growth overnight at 25°C. FusR was then purified using nickel columns (Qiagen).

### Nested deletion analyses {#S7}

Transcriptional fusions of the *ler* promoter with promoterless *lacZ* were described before^[@R31]^. To integrate the transcriptional fusions into the chromosome, *E.coli* MC4100 was lysogenized with phage λ45 and generating strains FS14 and FS16, respectively.

FusK purification and Reconstitution into Liposomes {#S8}
---------------------------------------------------

FusK was cloned into ZeroBlunt TOPO, digested using XhoI and HindIII restriction sites then cloned into pBADMycHisA. This plasmid was subsequently transformed into TOP10 cells, generating the ARP03 strain. ARP03 strain was grown LB at 37°C until OD600 0.5 then protein expression was induced by addition of a final concentration of 0.2% arabinose and growth for 5 hours at 30°C. Cells were collected, resuspended in 50mL of Lysis buffer (50mM phosphate buffer pH 8.0, 1% Deoxycholic acid, 10mM imidazol, 300mM NaCl, 15% Glycerol, 5mM DTT, 100uL protease inhibitor cocktail), then lysed using emulsiflex. Lysates were incubated 1 hour for solubilization then cleared by centrifugation at 18,000 rpm for 30 minutes. Soluble fraction was collected by ultracentrifugation at 45,000 rpm for 1 hour to obtain membrane fraction, then membranes were resuspended in lysis buffer and incubated with Nickel beads for 1 hour at 4°C with gentle agitation. Membrane suspension and clear lysates were loaded into nickel--NTA columns, washed with Wash Buffer (50mM phosphate buffer pH 8.0, 20mM imidazol, 300mM NaCl, 5mM DTT, 0.1% Deoxycholic acid) and eluted in three steps with elution buffer (250mM Imidazol, 300mM NaCl, 1mM DTT, 0.1% Deoxycholic Acid). Protein was concentrated using centricons with molecular cutoff of 30,000KDa, then its concentration was determined by Bradford. Liposomes were loaded with FusK at ratio 20:1. Liposomes were reconstituted as described previously ^[@R32]^. FusK presence into liposomes was confirmed by western blot using anti-Myc antibody (Invitrogen).

Autophosphorylation and Phosphotransfer Assays {#S9}
----------------------------------------------

Autophosphorylation assays were performed as described previously^[@R3]^. A concentration of 100μM L-fucose or D-glucose was used. The bands were quantified using IMAGEQUANT version \_ software. Quantification of triplets was performed. The Student t-test was used to determine statistical significance. A *P*-value of less than 0.05 was considered significant.

RNA extraction and Real-Time PCR {#S10}
--------------------------------

RNA from six biological replicates (experiments performed three independent times, total of 18 independent biological replicates) was extracted using RiboPure kit according to manufacturer's instructions. Primer validation and real time PCR was performed as describe previously ^[@R33]^. Gene expression is represented as fold differences compared to the wild type strain 86-24. The error bars indicate the standard deviations of the ΔΔC~T~ values. The Student t-test was used to determine statistical significance. A *P*-value of less than 0.05 was considered significant.

Microarrays {#S11}
-----------

Microarrays and analysis were performed as previously described ^[@R34]^. The GeneChip E. coli Genome 2.0 array system of the Affymetrix system was used to compare the gene expression in strain 86-24 to that in *fusK-* and *fusR-* strains. The output from the scanning of the Affymetrix GeneChip^®^ *E. coli* 2.0 were obtained using GCOS v 1.4 according to manufacturer's instructions. Comparisons were performed using the analysis tools within GCOS v 1.4, by selecting the appropriate array, CHP file for comparison, and baseline values. Custom analysis scripts were written in Perl to complete multiple array analyses. Expression data can be accessed using accession number (GSE34991) at the NCBI GEO database.

Fluorescent Actin Staining (FAS) Assay {#S12}
--------------------------------------

Fluorescein actin staining (FAS) assays were performed as previously described^[@R35]^. Pedestal enumeration was performed in 600 infected cells. The Student t-test was used to determine statistical significance. A *P*-value of less than 0.05 was considered significant.

*In vitro* competition assays {#S13}
-----------------------------

Bacterial strains were grown for 18 hours in LB at 37°C, resuspended in DMEM no glucose and inoculated 1:100 in DMEM (no glucose, no pyruvate) containing fucose or mucin as sole carbon source. *B.theta* was grown in TYG medium, resuspended in DMEM no glucose and inoculated at 1:9 ratio. *In vitro* competitions were carried out anaerobically and samples were collected hourly for serial dilution and plating for cfu count. A competition index was determined by the ratio of *fusK*- to WT EHEC or *fusK*-to *ler*-.

Infant rabbit infection studies {#S14}
-------------------------------

Litters of 3-day old infant rabbits were infected as described previously (Ritchie et al 2003). Individual rabbits were oro-gastrically inoculated (approx. 5 × 10^8^ cfu per 90g) with 1:1 mixtures of wild type (*lacZ*−) EHEC and the *fusK-* of *fusKfucR*- mutants. The animals were necrotized 2 days post-inoculation and colonic tissue samples removed and homogenized prior to microbiological analysis. The number of wild type and *fusK* mutant cells present in the tissue homogenate was determined by serial dilution and plating on media containing Sm and bromo-chloro-indoyl-galactopyranoside (X-gal) as previously described (Ritchie et al 2003). Competition indexes (CI) were calculated as the ratio of *fusK* to wild type or *fusKfucR* to wild type in tissue homogenates divided by the ratio of *fusK* to wild type or *fusKfucR* to wild type in the input. The CI was compared to the CI value obtained when otherwise isogenic *lacZ*+ (wild type) and *lacZ*− strains were given to rabbits. Differences in CIs were compared using the Mann-Whitney test, where a *P*-value of less than 0.05 was considered significant. All animal experiments were performed were approved by the IACUC offices of UT Southwestern Medical Center and Brigham and Women's Hospital. (*n*=2 litters \[6--11 animals\] Δ*lacZ* and Δ*fusK*Δ*fucR*, *n*=3 litters \[11 animals\])

β-galactosidase activity assays {#S15}
-------------------------------

The bacterial strains FS14, FS15 and FS16 were transformed with pFusR or empty vector (pBADMycHisA) and grown in aerobically in DMEM containing 0.2% arabinose at 37°C to an OD~600~ of 0.8. The cultures were diluted 1:100 in Z buffer (60mM Na~2~HPO~4~.7H~2~O, 50mM β-mercaptoethanol) and assayed for β-galactosidase activity by using o-nitrophenyl-β-D-galactopyranoside as substrate as previously described ^[@R36]^.

Electrophoretic Mobility Shift Assay (EMSA) {#S16}
-------------------------------------------

EMSAs were performed using purified FusR-Myc-His and radiolabelled probes. Primers were end-labelled using \[γ^32^P\]ATP and T4 polynucleotide kinase (NEB), and subsequently used on a PCR to generate radiolabelled probes. End-labelled amplicons were run on a 6% polyacrylamide gel, excised, and purified using Qiagen Gel Extraction kit. To test the ability of FusR to directy bind to its target promoters, increasing amounts of FusR (0 to 4.35uM) were incubated with end-labelled probe (10 ng) for 20 minutes at 4°C in binding buffer (500ug/mL BSA, 50ng poly-dIdC, 6-mM HEPES pH 7.5, 5mM EDTA, 3mM DTT, 300mM KCl and 25mM MgCl2). A sucrose solution was used to stop the reaction ^[@R29]^. The reactions were run on a 6% polyacrylamide gel for 6 hours and 30 minutes at 180V. The gels were dried under vacuum and EMSAs were visualized by autoradiography.

DNAseI Footprinting {#S17}
-------------------

DNAseI footprint was performed as previously described ^[@R37]^. Briefly: primer Ler-18FP-R (Table 2) was end-labeled using \[γ^32^P\]ATP and T4 polynucleotide kinase (NEB) and used in a PCR with cold primer Ler-299FP-F (Table 2) to generate probe LerFP. The resulting end-labeled probe was used in binding reaction (described above in EMSA) for 20 min at room temperature. At this time, 1:100 dilution of DNAseI (NEB) and the manufacturer-supplied buffer were added to the reaction and digestion proceeded for 7 min at room temperature. The digestion reaction was stopped by addition of 100uL of stop buffer (200mM NaCl, 2mM EDTA and 1% SDS). Protein extraction was performed by phenol-chroloform and DNA was precipitated using 5M NaCl, 100% ethanol and 1uL glycogen. The DNAse reactions were run in a 6% polyacrylamide-urea gel next to a sequencing reaction (Epicentre). Amplicon generated using primers Ler-299FP-F and Ler-18FP-R (radiolabeled) was used as a template for the sequencing reaction. Footprint was visualized by autoradiography.
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![The TCS FusKR of EHEC\
**a,** The QseC/QseE signaling-cascade. QseC senses AI-3/epinephrine(Epi)/NE. QseE senses Epi/NE/SO~4/~PO~4~. QseC phosphorylates QseB that activates flagella; KpdE that activates the LEE; and QseF. QseE only phosphorylates QseF. QseBC and QseEF repress expression of *z0462/z0463*. **b,** qRT-PCR of *z0462* in WT, Δ*qseB*, Δ*qseC*, Δ*qseE* and Δ*qseF* in DMEM. Gene expression is represented as fold differences normalized to WT. Error bars indicate standard deviations of ΔddCt values. (*n*=18 biological samples per strain; asterisk, *P*≤0.01; two asterisks, *P*≤0.001; Student's *t*-test). **c,** EMSA of *z0463* with QseB and QseF. **d,** EMSA of *qseE* (positive control) with QseF. **e,** Autophosphorylation of Z0462 in liposomes (top panel), and Commassie gel of Z0462 (lower panel) (loading control). **f,** Phosphotransfer from Z0462 (in liposomes) to Z0463 (ratio 1 HK: 4 RR) (top panel), Commassie gel of Z0462 and Z0463 (lower panel) (loading control).](nihms410949f1){#F1}

![Z0462/z0463 regulates LEE expression\
**a,** qRT-PCR of LEE genes in WT and *z0462*− in DMEM. **b,** qRT-PCR of *ler* in WT, *z0462*− and *z0462+* in DMEM. **c,** qRT-PCR of LEE genes in WT and *z0463*− in DMEM. **d,** qRT-PCR of *ler* in WT, *z0463*− and *z0463+* in DMEM. (*n*=18 biological samples per strain; two asterisks, *P* ≤ 0.001; three asterisks, *P*\<0.0001; ns, *P*\>0.05; Student's *t*-test). **e,** Representation of the Ler and Z0463 regulation of the LEE operons. **f,** EMSA of *ler* with Z0463 with *ler* and *kan* cold probes. **g,** Western-blot of EspB in supernatants of WT, *z0462*−, *z0462+*, *z0463*− and *z0463+* strains. BSA was added as a loading control. **h,** FAS assay of HeLa cells infected with EHEC WT, *z0462*−, *z0462+*, *z0463*− and *z0463+*, stained with FITC-phalloidin (actin) and propidium-iodide (bacteria and HeLa DNA).**i,** Quantification of FAS assay (*n*=600 cells; three asterisks, *P*\<0.0001; ns, *P*\>0.05; Student's *t*-test).](nihms410949f2){#F2}

![Z0462/Z0463 is a fucose sensing TCS\
**a,** qRT-PCR of *z0463* in WT in the presence of undifferentiated non-mucus-producing HT29 or differentiated HT29 mucus-producing cells. Error bar indicates standard deviations of ΔddCt values. (*n*=18 biological samples per assay; three asterisks, *P*\<0.0001; Student's *t*-test). **b,** qRT-PCR of fucose-utilization genes in EHEC WT, *z0462*− and *z0463*− in DMEM (OD~600~1.0). (*n*=18 biological samples per strain; asterisk, *P* ≤ 0.05; two asterisks, *P* ≤ 0.01; three asterisks, *P* ≤ 0.001; Student's *t*-test). **c,** Growth curves of WT, *z0462*− and *z0463*− strains in M9-minimal-media with L-fucose as a sole C-source. (*n*=6 biological samples; significance between generation times calculated through Anova *P* ≤ 0.01). **d,** FusK autophosphorylation (in liposomes) in the presence of L-fucose, D-glucose or D-ribose (top panel), and Commassie gel of FusK in liposomes (lower panel) (loading control). **e,** Quantification of FusK autophosphorylation. Phosphorylation represented at fold-change compared to absence of signal. Error bar indicates the standard deviation of fold-change values. (n=3; three asterisks, *P*\<0.0001; ns, *P*\>0.05; Student's *t*-test). **f,** Schematic representation of the *fusRK* operon to *z0461*. **g,** qRT-PCR of *z0461* in WT and Δ*fusK*. (*n*=18 biological samples per assay; two asterisks, *P*\<0.001; Student's *t*-test). **h,** Growth curves of WT and Δ*z0461* in M9-medium with fucose as a sole C-source. (*n*=6 biological samples; significance between generation times calculated through Anova *P* ≤ 0.01). **i,** qRT-PCR of *fucA, fucP* and *fucR* in WT and Δ*z0461*. (*n*=18 biological samples per strain; three asterisks, *P*\<0.001; Student's *t*-test).](nihms410949f3){#F3}

![FusK in pathogen-microbiota-host associations\
**a,** qRT-PCR of *ler* in WT or Δ*fusK*. RNAs extracted from cultures grown in M9 with either D-glucose or L-fucose as sole C-sources. Error bar indicates standard deviations of ΔddCt values. (*n*=18 biological samples per assay; asterisk, *P*\<0.02; two asterisks, *P*\<0.01; ns, *P*\>0.05; Student's *t*-test). **b,** qRT-PCR of *ler* in WT in the absence/presence of *B.thetaiotaomicron*. RNAs from cultures grown in DMEM containing L-fucose or mucin. Error bar indicates standard deviations of ΔddCt values. (*n*=18 biological samples per assay; two asterisks, *P*\<0.01; three asterisks, *P*\<0.0001; ns, *P*\>0.05; Student's *t*-test). **c,** Competition assays between WT andΔ*fusK* or Δ*fusKfucR*. 1:1 mixtures of *fusK* and WT EHEC or *lacZ*− and *lacZ*+ (WT) or *fusKfucR* and WT were intragastrically inoculated into infant rabbits. CFU in the mid-colon were determined 2-days post-inoculation. Each point represents a competitive index. Bars represent the geometric mean value for each group. (*n*=2 litters \[6--11 animals\]Δ*lacZ* and Δ*fusK*Δ*fucR*, *n*=3 litters \[11 animals\]Δ*fusK*; asterisk, *P*\<0.05; Mann-Whitney test).](nihms410949f4){#F4}
